- Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs” SciTechDaily
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Weight-loss jabs linked to reduced risk of 42 conditions including dementia The Guardian
- Do GLP-1 drugs have health risks beyond their weight loss benefits? Medical News Today
- GLP-1s: Good News, Bad News Medscape